BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29710478)

  • 1. Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function.
    Wang F; Wu Y; Xie X; Sun J; Chen W
    Biomed Pharmacother; 2018 Mar; 99():798-809. PubMed ID: 29710478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nuclear bile acid receptors for liver disease.
    Trauner M; Baghdasaryan A; Claudel T; Fickert P; Halilbasic E; Moustafa T; Zollner G
    Dig Dis; 2011; 29(1):98-102. PubMed ID: 21691114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptors in acute and chronic cholestasis.
    Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
    Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
    Sugden MC; Holness MJ
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
    Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
    Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor modulators (2011 - 2014): a patent review.
    Sepe V; Distrutti E; Fiorucci S; Zampella A
    Expert Opin Ther Pat; 2015; 25(8):885-96. PubMed ID: 26183029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of gastrointestinal and liver cancers: role of bile acid activated nuclear receptors.
    Renga B; Mencarelli A; Cipriani S; Distrutti E
    Curr Top Med Chem; 2012; 12(6):625-36. PubMed ID: 22242858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors as new perspective for the management of liver diseases.
    Trauner M; Halilbasic E
    Gastroenterology; 2011 Apr; 140(4):1120-1125.e1-12. PubMed ID: 21334334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of gene expression by novel metabolic intermediates.
    Gustafsson JA
    J Steroid Biochem Mol Biol; 2015 Sep; 153():102-4. PubMed ID: 25869558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
    Fuchs CD; Traussnigg SA; Trauner M
    Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escalation of liver malfunctioning: A step toward Herbal Awareness.
    Sultana B; Yaqoob S; Zafar Z; Bhatti HN
    J Ethnopharmacol; 2018 Apr; 216():104-119. PubMed ID: 29309862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.
    Arrese M; Karpen SJ
    Clin Pharmacol Ther; 2010 Apr; 87(4):473-8. PubMed ID: 20200515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptors in liver disease.
    Wagner M; Zollner G; Trauner M
    Hepatology; 2011 Mar; 53(3):1023-34. PubMed ID: 21319202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.
    Fiorucci S; Cipriani S; Baldelli F; Mencarelli A
    Prog Lipid Res; 2010 Apr; 49(2):171-85. PubMed ID: 19932133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.
    Handschin C; Meyer UA
    Arch Biochem Biophys; 2005 Jan; 433(2):387-96. PubMed ID: 15581595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR: a metabolic regulator and cell protector.
    Wang YD; Chen WD; Moore DD; Huang W
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
    Nie YF; Hu J; Yan XH
    J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the regulation of lipid metabolism and the mechanism of the aqueous and ethanol extracts of Usnea.
    Zhu J; Zhang X; Chen X; Sun Y; Dai Y; Chen C; Zhang T; Yan Z
    Biomed Pharmacother; 2017 Oct; 94():930-936. PubMed ID: 28810520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.